Institutional Readiness for Managing COVID-19 Vaccine Pfizer-BioNTech in Trusts

Ian Allen, Pharmacy Quality Assurance Regional Specialist (NW), North West Pharmaceutical Quality AssurancePublished Last updated See all updates

Must read guidance for Chief Pharmacists and others in Trusts on the COVID-19 Vaccine Pfizer-BioNTech.


The attachment below outlines the medicines management responsibilities of Chief Pharmacists for Mass Vaccination in Hub and Non-Hub Trust sites, and provides supporting guidance and resources in relation to:

  • Safe storage and distribution, including temperature controlled storage and safe handling of materials at ultra-low temperatures, stock control, and reporting vaccine usage to PHE
  • Oversight of vaccine handling and preparation, including management of shelf life reduction processes following defrosting

The document aims to promote consistency of practice by providing flow diagrams outlining a stepwise approach to implementing Pharmacy processes to receive, store and issue vaccines, and to oversee vaccine handling processes by clinical staff.


Other handling content for Trusts

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional in England, get in touch with us if you still have questions

Change history

  1. Post thaw refrigerated expiry extended to 31 days
  1. Added SOP for thawing small numbers of vaccine vials
  1. Amendment of instructions for disposal of cartons to use of confidential waste stream, plus various minor updates - see change log in document
  1. Published